[JinkoSolar Resumes Production at its Haining Facility SHANGHAI, October 11, 2011 - The Haining facility, one of two JinkoSolar production facilities, suspended production on September 17, 2011, after an accident involving suspected leakage of fluoride from a waste storage warehouse into a nearby small water channel due to extreme and unforeseen weather conditions. The Company has taken all the steps]
[JinkoSolar Resumes Production at its Haining Facility SHANGHAI, October 11, 2011 - The Haining facility, one of two JinkoSolar production facilities, suspended production on September 17, 2011, after an accident involving suspected leakage of fluoride from a waste storage warehouse into a nearby small water channel due to extreme and unforeseen weather conditions. The Company has taken all the steps]
[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 39,606 Item 6: 0 Item 7: 1,195,048 Item 8: 0 Item 9: 1,195,048 Item 11: 6.151% Item 12: HC Cusip #G2110J104 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 1,195,048 Item 8: 0 Item 9: 1,195,048 Item 11: 6.151%]
[JOINT FILING AGREEMENT Joint Filing Agreement This Agreement may be executed in counterparts and each of such counterparts taken together shall constitute one and the same instrument. Dated Morgan Stanley MSRESS III, Inc. MSRESS III Manager, L.L.C.]
[SHARE TRANSFER CONTRACT OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. BY AND BETWEEN SHAANXI AOXING PHARMACEUTICALS CO., LTD. AND SHAREHOLDERS OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. INDEX CHAPATER I DEFINITION AND INTERPRETATION 4 ARTICLE 1 DEFINITION 4 CHAPATER II TRANSFERRED SHARES 5 ARTICLE 2 SHARE TRANSFER 5 ARTICLE 3 TRANSFER PRICE 5 ARTICLE 4 CONDITIONS FOR THE PAYMENT OF] [Form Non-competition Agreement Agreement This Non-competition Agreement (this “ Party A: Shaanxi Weinan Huaren Pharmaceuticals Co., Ltd., a company incorporated under PRC law, with its business license registered number [_] and its legal address registered at No. 13, Weihua Road, Weinan City, Shaanxi Province; Party B: [_], a PRC citizen with the ID number [_]. Whereas Equity Interests Article 1] [BIOSTAR PHARMACEUTICALS SIGNS AGREEMENT TO ACQUIRE SHAANXI WEINAN HUAREN PHARMACEUTICALS, LTD . XIANYANG, China, October 11, 2011 -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced that its wholly owned subsidiary, Shaanxi Aoxing Pharmaceutical, Ltd., entered into a]
[SHARE TRANSFER CONTRACT OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. BY AND BETWEEN SHAANXI AOXING PHARMACEUTICALS CO., LTD. AND SHAREHOLDERS OF SHAANXI WEINAN HUAREN PHARMACEUTICALS CO., LTD. INDEX CHAPATER I DEFINITION AND INTERPRETATION 4 ARTICLE 1 DEFINITION 4 CHAPATER II TRANSFERRED SHARES 5 ARTICLE 2 SHARE TRANSFER 5 ARTICLE 3 TRANSFER PRICE 5 ARTICLE 4 CONDITIONS FOR THE PAYMENT OF] [Form Non-competition Agreement Agreement This Non-competition Agreement (this “ Party A: Shaanxi Weinan Huaren Pharmaceuticals Co., Ltd., a company incorporated under PRC law, with its business license registered number [_] and its legal address registered at No. 13, Weihua Road, Weinan City, Shaanxi Province; Party B: [_], a PRC citizen with the ID number [_]. Whereas Equity Interests Article 1] [BIOSTAR PHARMACEUTICALS SIGNS AGREEMENT TO ACQUIRE SHAANXI WEINAN HUAREN PHARMACEUTICALS, LTD . XIANYANG, China, October 11, 2011 -- Biostar Pharmaceuticals, Inc. (NASDAQ GM: BSPM) ("Biostar" or "the Company"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, today announced that its wholly owned subsidiary, Shaanxi Aoxing Pharmaceutical, Ltd., entered into a]
[CUSIP No. G6647N108 1. Names of Reporting Persons. I.R.S. Identification Nos. ofove persons (entities only). Morgan Stanley 2. Check the Appropriate Box if a Member of a (See Instructions) (a)[] (b)[ ] 3. SEC Use Only 4. Citizenship or Place of Organization Delaware 5. Sole Voting Power Number of] [JOINT FILINGREEMENT Joint Filingreement Thisreement may be executed inunterparts and each of suchunterparts taken together shallnstitute one and theme instrument.ted Morgan Stanley MSRESS III, MSRESS III Manager, L.L.C. Morgan Stanley Real Estateecial Situations IIIGP, L.L.C. Morgan Stanley Real Estateecial Situations Fund III, L.P.]
[For further information contact: Brad Miller, Investor Relations Director Country/City Code 8862 Tel: 2656-8016 brad.miller@gigamedia.com.tw GigaMedia Updates Restructuring of IAH Games Games Games TAIPEI, Taiwan, October 7, 2011 GigaMedia Limited (NASDAQ: GIGM) announced today that as part of the companys strategic restructuring and new strategic growth plans, its IAH Games Games In accordance with the agreement, IAH Games IAH] [For further information contact: Brad Miller, Investor Relations Director Country/City Code 8862 Tel: 2656-8016 brad.miller@gigamedia.com.tw GigaMedia Receives Nasdaq Notification of Non-Compliance with Minimum Bid Price Rule In accordance with Nasdaq Marketplace Rule 5810(c)(3)(A), GigaMedia has been provided a grace period of 180 calendar days, or until March 26, 2012, to regain compliance by maintaining a closing bid price of at]
[SHARE TRANSFERNTRACT OF SHAANXI WEINAN HUAREN PHARMACEUTICALS BY AND BETWEEN SHAANXI AOXING PHARMACEUTICALS AND SHAREHOLDERS OF SHAANXI WEINAN HUAREN PHARMACEUTICALS INDEX CHAPATER I DEFINITION AND INTERPRETATION 4 ARTICLE 1 DEFINITION 4 CHAPATER II TRANSFERRED SHARES 5 ARTICLE 2 SHARE TRANSFER 5 ARTICLE 3 TRANSFER PRICE] [Form Non-competitionreementreement This Non-competitionreement (this Party A:Shaanxi Weinan Huaren Pharmaceuticals ampanyorporated under law, with its business license registered number [_] and its legaldress registered at No. 13, Weihua Road, Weinan City, Shaanxi Province; Party B:[_], a citizen with the ID number [_].] [BIOSTAR PHARMACEUTICALS SIGNSREEMENT TO ACQUIRE SHAANXI WEINAN HUAREN PHARMACEUTICALS, . XIANYANG, China, October 11, 2011 -- Biostar Pharmaceuticals, (NASDAQ GM: BSPM) ("Biostar" or "thempany"), a developer, manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases andnditions, today announced that its wholly owned subsidiary, Shaanxi Aoxing Pharmaceutical, entered into a Share]
[Form 6-K TABLE OF CONTENTS Page 3 Date of Meeting of the Board of Directors 4 2]
